Misr International University Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2015
NCT02808624
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Christian Blind Mission | Fixed Prosthodontics Department, Misr International University | Misr International University

Active Ingredients

Drugs in Phase 3 Trials (3)

acetylcysteine (mucomyst) (1 trial)

chlorhexidine (hibitane) (2 trials)

moringa oleifera (1 trial)

Drugs in Phase 2 Trials (1)

l-carnosine (1 trial)

Drugs in Other Trials (1)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Plaque (Phase 3)

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5